Cart
sales@molnova.com
Tyrphostin AG 112
CAS No. 144978-82-5
Tyrphostin AG 112( —— )
Catalog No. M22092 CAS No. 144978-82-5
Tyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 122 | In Stock |
|
| 50MG | 179 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 647 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTyrphostin AG 112
-
NoteResearch use only, not for human use.
-
Brief DescriptionTyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
-
DescriptionTyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number144978-82-5
-
Formula Weight236.23
-
Molecular FormulaC13H8N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (529.15 mM)
-
SMILESNC(=C(/C#N)C#N)\C(C#N)=C\c1ccc(O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rodrigo Franco, et al. Epidermal Growth Factor Receptor Is Activated by Hyposmolarity and Is an Early Signal Modulating Osmolyte Efflux Pathways in Swiss 3T3 Fibroblasts. Pflugers Arch. 2004 Mar;447(6):830-9.
molnova catalog
related products
-
HKI-357
HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 (IC50s: 34 nM and 33 nM). HKI-357 suppresses EGFR autophosphorylation (at Y1068), and AKT and MAPK phosphorylation.
-
EGF816 mesylate
EGF816 (Nazartinib) is a potent, irreversible, mutant-selective EGFR inhibitor with Ki and Kinact of 31 nM and 0.222 min-1, respectively.
-
Pyrotinib
Pyrotinib (SHR-1258)?is a potent and selective EGFR/HER2 dual inhibitor with IC50 of 13/38 nM, respectively.
